Literature DB >> 16906094

Survival of tumor megaprostheses replacements about the knee.

Hannah D Morgan1, Amy M Cizik, Seth S Leopold, Douglas S Hawkins, Ernest U Conrad.   

Abstract

UNLABELLED: Limb salvage surgery is an effective procedure with a low risk of tumor recurrence. In an attempt to define the incidence of implant failure at 2, 5, and 10 years postoperatively, we retrospectively reviewed implant survival in a group (n = 105) of pediatric (< 18 years of age) and adult patients who were treated with distal femoral and/or proximal tibial implants for extremity tumors. Issues regarding the timing of failure, reason for failure, and whether pediatric patients had higher rates of failure were posed as secondary questions. The median followup was 57 months (1-235 months). Thirty-two (32/105, 31%) patients had 42 implant failures. The mean prosthesis Kaplan-Meier survivorship of the index group was 84% at 2 years, 73% at 5 years, and 59% at 10 years. Forty-seven percent of all failures occurred within 2 years postoperatively, and 69% occurred within 5 years postoperatively. Pediatric patients had a higher failure rate than adults (42% versus 24%). Aseptic loosening was the most common reason for failure (n = 18/32; 56%). The incidence of failure in tumor megaprostheses is similar to early published literature and the incidence of these failures is highest within the first 3 years. LEVEL OF EVIDENCE: Therapeutic study, level IV.

Entities:  

Mesh:

Year:  2006        PMID: 16906094     DOI: 10.1097/01.blo.0000229330.14029.0d

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  [Megaprostheses of the knee joint].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2010-10       Impact factor: 1.087

2.  Joint-sparing or physeal-sparing diaphyseal resections: the challenge of holding small fragments.

Authors:  Manish Agarwal; Ajay Puri; Ashish Gulia; Kishore Reddy
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

3.  Does Microwave Ablation of the Tumor Edge Allow for Joint-sparing Surgery in Patients With Osteosarcoma of the Proximal Tibia?

Authors:  Jing Li; Zheng Guo; Zhen Wang; Hongbin Fan; Jun Fu
Journal:  Clin Orthop Relat Res       Date:  2015-07-08       Impact factor: 4.176

4.  [Proximal tibial reconstruction with gastrocnemius flap].

Authors:  K Trieb; M Göggel; H-R Dürr
Journal:  Oper Orthop Traumatol       Date:  2012-07       Impact factor: 1.154

5.  Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee.

Authors:  Chunlin Zhang; Jianping Hu; Kunpeng Zhu; Tao Cai; Xiaolong Ma
Journal:  Int Orthop       Date:  2018-02-09       Impact factor: 3.075

6.  Revision Distal Femoral Arthroplasty With the Compress(®) Prosthesis Has a Low Rate of Mechanical Failure at 10 Years.

Authors:  Melissa N Zimel; German L Farfalli; Alexandra M Zindman; Elyn R Riedel; Carol D Morris; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2015-09-22       Impact factor: 4.176

7.  Early follow-up of a custom non-fluted diaphyseal press-fit tumour prosthesis.

Authors:  Patrick W O'Donnell; Anthony M Griffin; William C Eward; Amir Sternheim; Jay S Wunder; Peter C Ferguson
Journal:  Int Orthop       Date:  2013-09-05       Impact factor: 3.075

8.  Compress periprosthetic fractures: interface stability and ease of revision.

Authors:  Wakenda K Tyler; John H Healey; Carol D Morris; Patrick J Boland; Richard J O'Donnell
Journal:  Clin Orthop Relat Res       Date:  2009-06-30       Impact factor: 4.176

9.  What was the survival of megaprostheses in lower limb reconstructions after tumor resections?

Authors:  Rodolfo Capanna; Guido Scoccianti; Filippo Frenos; Antonio Vilardi; Giovanni Beltrami; Domenico Andrea Campanacci
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

10.  Compressive osseointegration of tibial implants in primary cancer reconstruction.

Authors:  Richard J O'Donnell
Journal:  Clin Orthop Relat Res       Date:  2009-08-04       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.